FBXL14 abolishes breast cancer progression by targeting CDCP1 for proteasomal degradation.
Oncogene
; 37(43): 5794-5809, 2018 10.
Article
in En
| MEDLINE
| ID: mdl-29973690
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antigens, CD
/
Cell Adhesion Molecules
/
MicroRNAs
/
Ubiquitin-Protein Ligases
/
F-Box Proteins
/
Triple Negative Breast Neoplasms
/
Neoplasm Proteins
Type of study:
Prognostic_studies
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Oncogene
Journal subject:
BIOLOGIA MOLECULAR
/
NEOPLASIAS
Year:
2018
Document type:
Article
Country of publication:
United kingdom